Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Laura Mesana"'
Autor:
Nadya Prood, Laura Mesana, Meaghan Roach, Rozanne Wilson, Nana Rezai, Maria Cecilia Vieira, Suepattra G. May
Publikováno v:
Journal of the National Comprehensive Cancer Network. 21:HSR23-113
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::722eaeb13de5b7a861826c43fc73fc22
https://doi.org/10.6004/jnccn.2022.7201
https://doi.org/10.6004/jnccn.2022.7201
Autor:
Rozanne Wilson, Maria Cecilia Vieira, Meaghan Roach, Nadya Prood, Anjali Belani, Laura Mesana, Suepattra Grace May
Publikováno v:
Journal of Clinical Oncology. 41:33-33
33 Background: The COVID-19 pandemic generated unprecedented interruptions and impacts on healthcare services across the US, including cancer care delivery. Patient perspectives on navigating colorectal cancer (CRC) care throughout the pandemic have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37603fc97e2f750a9d6eda9a5d308475
https://doi.org/10.1200/jco.2023.41.4_suppl.33
https://doi.org/10.1200/jco.2023.41.4_suppl.33
Autor:
Dominik Naessens, Joris Diels, Margaux Welty, Laura Mesana, M Pacou, Amie Padhiar, Suzy Van Sanden
Publikováno v:
Current medical research and opinion. 36(4)
To compare the relative efficacy of ustekinumab (UST) vs. other therapies for 1-year response and remission rates in patients with moderate-severe UC. Randomized controlled trials reporting induction and maintenance efficacy of anti-TNFs (infliximab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26a596dfdf30855fb14613da03e943b4
https://pubmed.ncbi.nlm.nih.gov/32700987
https://pubmed.ncbi.nlm.nih.gov/32700987
Autor:
Laura Mesana
Publikováno v:
Health Science Inquiry. 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9933d736158ab4ebdfd1f947d0930c3
https://doi.org/10.29173/hsi151
https://doi.org/10.29173/hsi151
Publikováno v:
CMAJ Open. 4:E222-E229
BACKGROUND Medical end-of-life practices are hotly debated in Canada, and data from other countries are used to support arguments. The objective of this pilot study was twofold: to adapt and validate a questionnaire designed to measure the prevalence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea92fddf0a472e3caacc2f1c969fbe39
https://doi.org/10.9778/cmajo.20150084
https://doi.org/10.9778/cmajo.20150084
Autor:
Joris Diels, Dominik Naessens, Laura Mesana, Margaux Welty, M Pacou, Amie Padhiar, Suzy Van Sanden
Publikováno v:
American Journal of Gastroenterology. 114:S462-S463
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6baf204a9a892c9e2d3c9e3c8be1a64c
https://doi.org/10.14309/01.ajg.0000592736.89559.4d
https://doi.org/10.14309/01.ajg.0000592736.89559.4d
Autor:
Ryan Chan, Michelle Maklin, Dai Une, Roy G. Masters, Vincent Chan, Thierry G. Mesana, Laura Mesana, Marc Ruel
Publikováno v:
Circulation. 132:741-747
Background— Our objectives were to identify correlates of mortality and congestive heart failure after aortic valve replacement (AVR) according to preoperative left ventricular (LV) function and to describe the incidence, time course, and correlate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05b661cc6eec4e754812ff8f7f82f609
https://doi.org/10.1161/circulationaha.115.015371
https://doi.org/10.1161/circulationaha.115.015371
Publikováno v:
Airway Pharmacology and Treatment.
Background: Reslizumab (RES) and benralizumab (BEN) have been developed to target severe eosinophilic asthma phenotypes, but no studies directly compare RES to BEN on clinical endpoints. Aim/Objective: To assess the relative treatment effect of RES c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9bdf5c3d6bcd93a8b738fe0d1f251bc6
https://doi.org/10.1183/1393003.congress-2017.oa2903
https://doi.org/10.1183/1393003.congress-2017.oa2903
Autor:
Emily Manthorp, Hadi Toeg, Jennifer M. Renaud, Darryl R. Davis, Stephanie Thorn, Brian McNeill, Myra Kordos, Robert A. deKemp, Erik J. Suuronen, Ali Ahmadi, Jean N. DaSilva, Laura Mesana, Branka Vulesevic, Thierry G. Mesana, Marc Ruel, Rob S. Beanlands, Drew Kuraitis
Publikováno v:
Biomaterials. 35:4749-4758
Injectable delivery matrices hold promise in enhancing engraftment and the overall efficacy of cardiac cell therapies; however, the mechanisms responsible remain largely unknown. Here we studied the interaction of a collagen matrix with circulating a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89a6ec8a44db8e816da80c1951c0e5d2
https://doi.org/10.1016/j.biomaterials.2014.02.028
https://doi.org/10.1016/j.biomaterials.2014.02.028
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice. 7:122-130.e1
Background The interaction of IL-5 with its receptor on eosinophils increases the activation and maintenance of eosinophils; blocking this interaction reduces asthma symptoms in patients with the eosinophilic phenotype. Reslizumab, which binds to IL-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc59ddbf7a63574e5bccf08c77c1a340
https://doi.org/10.1016/j.jaip.2018.08.036
https://doi.org/10.1016/j.jaip.2018.08.036